You have 9 free searches left this month | for more free features.

M032

Showing 1 - 25 of 1,259

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Glioblastoma Multiforme, Anaplastic Astrocytoma, Gliosarcoma Trial in Birmingham (M032, Pembrolizumab)

Recruiting
  • Glioblastoma Multiforme
  • +2 more
  • Birmingham, Alabama
    University of Alabama at Birmingham
Jan 30, 2023

Recurrent Glioblastoma Multiforme, Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma or Gliosarcoma Trial in

Active, not recruiting
  • Recurrent Glioblastoma Multiforme
  • +2 more
  • M032 (NSC 733972)
  • Birmingham, Alabama
    University of Alabama at Birmingham
Jan 26, 2022

Healthy Subject Trial in North York (ALS-4, Placebo)

Completed
  • Healthy Subject
  • North York, Ontario, Canada
    BioPharma Services Inc.
Apr 19, 2022

Atopic Dermatitis Eczema Trial in Canada, United States (ANB032, Placebo)

Recruiting
  • Atopic Dermatitis Eczema
  • Fountain Valley, California
  • +27 more
Jul 5, 2023

Ovarian Carcinoma Trial in Israel, United States (Denosumab, Salpingo-Oophorectomy)

Terminated
  • Ovarian Carcinoma
  • Denosumab
  • Salpingo-Oophorectomy
  • Boston, Massachusetts
  • +5 more
May 23, 2022

NonSegmental Vitiligo Trial in Canada, United States (INCB054707, Placebo)

Active, not recruiting
  • NonSegmental Vitiligo
  • Hoover, Alabama
  • +30 more
Nov 14, 2022

Recurrent Ovarian Cancer, Recurrent Fallopian Tube Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in Worldwide

Active, not recruiting
  • Recurrent Ovarian Cancer
  • +2 more
  • Relacorilant, 100mg QD
  • +3 more
  • Birmingham, Alabama
  • +20 more
Jun 27, 2022

Brain Tumors Trial in Canada, United States (temozolomide, thiotepa, carboplatin, 13-cis-retinoic acid)

Completed
  • Brain Tumors
  • temozolomide, thiotepa, carboplatin, 13-cis-retinoic acid
  • Phoenix, Arizona
  • +16 more
Jun 17, 2021

SARS-CoV-2 Infection, COVID-19 Trial in United Kingdom (SARS-CoV-2 rS/Matrix M1-Adjuvant, Placebo, Licensed seasonal influenza

Active, not recruiting
  • SARS-CoV-2 Infection
  • COVID-19
  • SARS-CoV-2 rS/Matrix M1-Adjuvant
  • +2 more
  • Belfast, Antrim, United Kingdom
  • +32 more
Oct 19, 2022

Chorea Associated With Huntington Disease Trial in Australia, Canada, United States (SD-809)

Completed
  • Chorea Associated With Huntington Disease
  • Birmingham, Alabama
  • +37 more
Nov 5, 2021

Multiple Myeloma Trial in Worldwide (Carfilzomib, Dexamethasone)

Completed
  • Multiple Myeloma
  • Scottsdale, Arizona
  • +139 more
Sep 9, 2022

Non-Cystic Fibrosis Bronchiectasis Trial in Worldwide (Brensocatib 10 mg, Brensocatib 25 mg, Placebo)

Recruiting
  • Non-Cystic Fibrosis Bronchiectasis
  • Brensocatib 10 mg
  • +2 more
  • Birmingham, Alabama
  • +416 more
Jan 24, 2023

Influenza, Human Trial in United States (NanoFlu, Fluzone Quadrivalent)

Unknown status
  • Influenza, Human
  • NanoFlu
  • Fluzone Quadrivalent
  • Hollywood, Florida
  • +18 more
Apr 16, 2020

Diabetes, Type 1 Trial in Worldwide (insulin icodec, insulin degludec, insulin aspart)

Completed
  • Diabetes Mellitus, Type 1
  • insulin icodec
  • +2 more
  • Concord, California
  • +98 more
Feb 2, 2023

Dravet Syndrome (DS) Trial in Worldwide (Soticlestat, Placebo)

Recruiting
  • Dravet Syndrome (DS)
  • Phoenix, Arizona
  • +95 more
Jan 10, 2023

Assessment of ASPIRE and HOPE Adherence

Completed
  • HIV Prevention
  • In-depth Interview (IDIs) or Focus Group Discussion (FGD)
  • Lilongwe, Malawi
  • +6 more
Oct 11, 2022

Brain Metastases Trial in Seoul (BT-M01)

Recruiting
  • Brain Metastases
  • BT-M01
  • Seoul, Song-pa Gu, Korea, Republic of
    Asan Medical Center
Oct 6, 2022

Breast Cancer, Metastatic Breast Cancer, Radiation Therapy Complication Trial in Seoul

Recruiting
  • Breast Cancer
  • +2 more
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Jun 8, 2023

    Parkinson Disease Trial in Seoul, Gyeonggi-do (MRI Imaging)

    Not yet recruiting
    • Parkinson Disease
    • MRI Imaging
    • Seoul, Nowon-gu, Korea, Republic of
    • +2 more
    Aug 22, 2022

    Lennox Gastaut Syndrome (LGS) Trial in Worldwide (Soticlestat, Placebo)

    Recruiting
    • Lennox Gastaut Syndrome (LGS)
    • Phoenix, Arizona
    • +109 more
    Jan 10, 2023

    Chronic Inflammatory Demyelinating Polyradiculoneuropathy Trial in Worldwide (HYQVIA, 0.25% albumin solution with rHuPH20,

    Completed
    • Chronic Inflammatory Demyelinating Polyradiculoneuropathy
    • HYQVIA
    • +2 more
    • Phoenix, Arizona
    • +82 more
    Feb 28, 2022

    Locally Recurrent/Metastatic Triple Negative Breast Cancer Trial in United States (radiation, drug, procedure)

    Recruiting
    • Locally Recurrent/Metastatic Triple Negative Breast Cancer
    • external beam radiation therapy
    • +2 more
    • Basking Ridge, New Jersey
    • +6 more
    Aug 8, 2022

    Venous Thromboembolism (VTE), Pulmonary Embolism, Deep Vein Thrombosis (DVT) Trial in Worldwide (Edoxaban, Standard of Care)

    Completed
    • Venous Thromboembolism (VTE)
    • +2 more
    • Tucson, Arizona
    • +139 more
    Jun 28, 2022

    Disease, Hodgkin Trial in Worldwide (brentuximab vedotin, )

    Completed
    • Disease, Hodgkin
    • brentuximab vedotin
    • placebo
    • Duarte, California
    • +86 more
    Apr 22, 2021

    Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Mitoxantrone hydrochloride liposome injection
    • +3 more
    • Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    Jul 1, 2023